The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pre-clinical modeling of navtemadlin pharmacokinetics (PK), pharmacodynamics (PD), and efficacy in glioblastoma, IDH-wildtype.
 
Rachael A. Vaubel
No Relationships to Disclose
 
Wenjuan Zhang
No Relationships to Disclose
 
Ann C Mladek
No Relationships to Disclose
 
Tugce I Pasa
No Relationships to Disclose
 
Katie L Waller
No Relationships to Disclose
 
Sylwia A Stopka
No Relationships to Disclose
 
Michael S Regan
No Relationships to Disclose
 
Paul A Decker
No Relationships to Disclose
 
Shiv K Gupta
No Relationships to Disclose
 
Sonia Jain
No Relationships to Disclose
 
Zeng Hu
No Relationships to Disclose
 
Brett L Carlson
No Relationships to Disclose
 
Katrina K Bakken
No Relationships to Disclose
 
Surabhi Talele
No Relationships to Disclose
 
Ju-Hee Oh
No Relationships to Disclose
 
Jeanette Eckel-Passow
Research Funding - Exact Sciences
 
Danielle M Burgenske
No Relationships to Disclose
 
Nathalie Agar
Research Funding - Bruker; EMD Serono/Merck; ITeos Therapeutics; Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - IP portfolio at Partners Healthcare for surgical margin delineation and intraoperative diagnosis largely based on mass spectrometry
 
William F Elmquist
No Relationships to Disclose
 
Jann Nagina Sarkaria
Consulting or Advisory Role - Travecta Therapeutics
Research Funding - Abbvie; ABL Bio; AstraZeneca; Boehringer Ingelheim; InhibRx; Karyopharm Therapeutics; Modifi Bio; Otomagnetics; Rain Therapeutics; Reglagene; SK Biopharmaceuticals; Sumitomo Dainippon Pharma Oncology; WUGEN, Inc.